Interim Analysis of a Prospective Study of Itolizumab for Treatment of Chronic Graft VS Host Disease Following Haematopoietic Stem Cell Transplantation
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI